<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02868541</url>
  </required_header>
  <id_info>
    <org_study_id>2013-29</org_study_id>
    <nct_id>NCT02868541</nct_id>
  </id_info>
  <brief_title>Assessment of Pharyngeal Carriage of Microorganisms Responsible for Transmissible Acute Respiratory Infections in HAJJ Pilgrims.</brief_title>
  <acronym>EMIRATH</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this project is to study the prevalence of viruses and bacteria responsible&#xD;
      for transmissible acute respiratory infections in the respiratory tract of pilgrims returning&#xD;
      from the trip. The patients included, will be the consultant pilgrims to the traveler health&#xD;
      center, and before leaving for Hajj. Based on the results obtained in previous studies, it is&#xD;
      estimated that 200 pilgrims will be included each year, 600 in total (inclusion period of 3&#xD;
      years). Respiratory secretions are then collected by nasal swab and throat (swab) prior to&#xD;
      departure for the hajj. In return, patients will be reconvened systematic consultation to&#xD;
      record medical events potentially encountered during the trip, and it will again be performed&#xD;
      the same nasal swabs and throat. It will then be performed on these samples' return from hajj&#xD;
      &quot;molecular detection (PCR and RT-PCR) of 35 viruses and bacteria respiratory tropism:&#xD;
      influenza (3), RSV (2), metapneumovirus (1), Coronavirus (4), Parainfluenzavirus (4),&#xD;
      enteroviruses (4), rhinovirus (1), adenovirus (6) bocavirus, polyomavirus (2), pneumococcus,&#xD;
      Bordetella pertussis, Mycoplasma pneumoniae, Chlamydophila pneumoniae, Haemophilus&#xD;
      influenzae, Neisseria meningitidis and Coxiella burnetii. Samples &quot;return of hajj&quot; positive&#xD;
      should be cultured for the isolation of the strain. For patients positive return, it will be&#xD;
      done further research of these 35 viruses and bacteria on samples &quot;start of hajj,&quot; the same&#xD;
      method described above. In addition to this systematic consultation, and if symptoms return,&#xD;
      the pilgrims will be seen in consultation for a diagnosis evaluation and therapeutic&#xD;
      management.&#xD;
&#xD;
      This study will shed light on the acquisition of microorganisms respiratory tropism during&#xD;
      the stay and on the potential risks associated with the circulation of these pathogens after&#xD;
      the trip.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The number of new viruses and/or bacteria identified and characterized by respiratory and pharyngeal carriage among pilgrims between the departure and the return of Hajj</measure>
    <time_frame>up to 3 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">420</enrollment>
  <condition>Acute Respiratory Infection</condition>
  <arm_group>
    <arm_group_label>Haaj pilgrim</arm_group_label>
    <description>Patient that are showing at the traveler hospital health center requiring the mandatory Meningococcal vaccine ACYW135</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Naso pharyngeal swab</intervention_name>
    <arm_group_label>Haaj pilgrim</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Travelers pilgrims over 18 years leaving for the Hajj pilgrimage and consulting at the&#xD;
        international vaccination service of the Public Assistance of Marseille Hositals for the&#xD;
        mandatory meningococcal ACYW135 vaccination.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All travelers presenting during the study period in the service of international&#xD;
             vaccination for mandatory meningococcal ACYW135 vaccination ,&#xD;
&#xD;
          -  Affiliated to a social security insurance regime&#xD;
&#xD;
          -  Male or Female&#xD;
&#xD;
          -  Aged over 18 years&#xD;
&#xD;
          -  Having signed informed consent form&#xD;
&#xD;
          -  able to understand and answer the study questions&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Patients aged under 18&#xD;
&#xD;
          -  Patient whose protocol compliance seems unlikely to investigator&#xD;
&#xD;
          -  Participant in another clinical trial or in exclusion period of a previous clinical&#xD;
             trial,&#xD;
&#xD;
          -  Unable to understand the nature and objectives of the study,&#xD;
&#xD;
          -  Refusing to sign the informed consent form.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Philippe GAUTRET, Dr</last_name>
    <phone>04 91 36 87 52</phone>
    <email>philippe.gautret@ap-hm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexandra GIULIANI</last_name>
    <phone>04 91 38 28 70</phone>
    <email>alexandra.giuliani@ap-hm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>philippe BROUQUI</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>August 11, 2016</study_first_submitted>
  <study_first_submitted_qc>August 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2016</study_first_posted>
  <last_update_submitted>August 16, 2016</last_update_submitted>
  <last_update_submitted_qc>August 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>microorganisms</keyword>
  <keyword>pilgrim</keyword>
  <keyword>hajj</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

